No. |
Cell type |
JCRB No.
|
Cell Name
|
Animal
|
Tissue
|
Profile
|
|
1 | general cells |
IFO50012 |
Pt K2 |
marsupial (potoroo, rat kangar |
kidney |
kidney, epithelial-like |
|
2 | general cells |
IFO50041 |
MBT2 |
mouse |
bladder |
bladder carcinoma |
|
3 | general cells |
IFO50069 |
Alexander cells |
human |
liver |
hepatoma, HBs antigen-positive. This cell line is the same cell line as PLF/PRF/5 (other name of PLC/PRF/5). |
|
4 | general cells |
IFO50277 |
5RP7 |
rat |
embryo |
fibroblast transformed by c-Ha-ras oncogene |
|
5 | general cells |
IFO50295 |
NB-1 |
human |
sympatho-adrenal cell |
neuroblastoma |
|
6 | general cells |
IFO50323 |
BOKU |
human |
uterine cervix |
cervical squamous cell carcinoma |
|
7 | general cells |
IFO50361 |
B2-17 |
human |
brain |
astrocytoma, thymidine kinase-deficient mutant of U-251 MG cells |
|
8 | general cells |
IFO50418 |
ASF-4-1 |
human |
skin fibroblast from upper arm |
Normal diploid (46, XY) fibroblast with limited life span. The ASF-4-1 and the ASF-4-2 lines were established from skins of the same donor at different ages. This cell line was taken from the donor at 36 years and 2 month-old |
|
9 | general cells |
IFO50428 |
CMK-86 |
human |
peripheral blood |
This cell line expresses GPIIb/IIIa. Contains alpha-granule. Contains platelet peroxidase activity. |
|
10 | general cells |
IFO50434 |
KALS-1 |
human |
brain |
GFAP is weakly positive. |
|
11 | general cells |
IFO50479 |
NAGL-1 |
human |
B cells |
The CDR III of this line has been sequenced. |
|
12 | general cells |
IFO50491 |
RNB |
rat |
brain |
RNB cells are the parent cells of MDM2-RNB cells (IFO 50490). |
|
13 | general cells |
JCRB0001 |
F9-41 |
mouse |
testis |
Mouse testicular teratocarcinoma cell line. |
|
14 | general cells |
JCRB0032 |
CCRF-SB |
human |
peripheral blood (buffy coat) |
leukemia, acute B lymphoblastic |
|
15 | general cells |
JCRB0068 |
Flow3000 |
human |
embryonic brain |
normal fibroblast |
|
16 | general cells |
JCRB0073 |
J-111 |
human |
peripheral blood |
The cell line deposited as a human acute monocytic leukemia but many data show this cell line is a subline of the HeLa. |
|
17 | general cells |
JCRB0077 |
PC-3 |
human |
lung |
adenocarcinoma, intermediately differentiated |
|
18 | general cells |
JCRB0101 |
A3/KAW |
human |
ascites |
lymphoma, malignant |
|
19 | general cells |
JCRB0114 |
LC4-1 |
human |
peripheral blood |
leukemia, acute non T lymphoblastic |
|
20 | general cells |
JCRB0116.2 |
U937 cl1-22 |
human |
pleural effusion |
lymphoma, histiocytic, low susceptible clone of U937 for HIV |
|
21 | general cells |
JCRB0131 |
RL-33 |
rabbit |
lung |
Japansese white rabbit lung cell line sensitive to HSV or VSV. |
|
22 | general cells |
JCRB0212 |
B82 |
mouse |
skin |
skin fibroblast, bromodeoxyuridine-resistant |
|
23 | general cells |
JCRB0226 |
COLO201 |
human |
colon |
adenocarcinoma |
|
24 | general cells |
JCRB0234.0 |
TYK-nu |
human |
ovary |
undifferentiated carcinoma |
|
25 | general cells |
JCRB0243 |
B-1 |
mouse |
testis |
Leydig cell tumor, estrogen-dependent, (BALB/c mouse) |
|
26 | general cells |
JCRB0421 |
3'-mRLN-30 |
rat |
liver |
liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat) |
|
27 | general cells |
JCRB0423 |
RS-A |
rat |
spleen |
spleen, spontaneously transformed cells, (Donryu rat) |
|
28 | general cells |
JCRB0504 |
TIG-1-50 |
human |
fetus lung |
fetal lung, normal diploid fibroblast, TIG-1, PDL=about 50 |
|
29 | general cells |
JCRB0521 |
MRC-5-30 |
human |
fetus lung |
fetal lung, normal diploid fibroblast, PDL=about 30 |
|
30 | general cells |
JCRB0539 |
TIG-113 |
human |
skin |
Human normal fibroblast from skin. |
|
31 | general cells |
JCRB0624 |
HSC-4 |
human |
tongue |
Human squamous carcinoma cell line from tongue. |
|
32 | general cells |
JCRB0625 |
Ca9-22 |
human |
gingival |
squamous carcinoma, gingiva |
|
33 | general cells |
JCRB0727 |
A9(An4)-2 |
human chromosome-introduced |
hybrid |
contains human chromosome # 1 (MTA with Tottori Univ. is required.) |
|
34 | general cells |
JCRB1004 |
Kasumi-3 |
human |
blood |
A novel human leukemia cell line established from blast cells of a patient attaked by myeloperoxidase-negative acute leukemia. |
|
35 | general cells |
JCRB1006.5 |
OUMS-36T-5 |
human |
embryo |
hTRT gene transfected normal human embryo fibroblast cell line. |
|
36 | general cells |
JCRB1024 |
Kasumi-6 |
human |
peripheral blood |
Human acute myeloid leukemia cell line with dominant negative mutation in the C/EBP alpha gene. |
|
37 | general cells |
JCRB1043 |
OVISE |
human |
metastatic forcus of the innominate |
Human cell line derived from ovarian tumor. |
|
38 | general cells |
JCRB1049 |
OVMIU |
human |
ovary |
Human cell line derived from ovarian tumour. |
|
39 | general cells |
JCRB1207 |
SV |
mouse |
skin (beta-gal deficient mouse) |
SV40 immortalized beta-galactosidase gene deficient mouse fibroblast cell line. Human disease animal model mouse (GM1 gangliosidosis) derived cell line. |
|
40 | general cells |
JCRB1316.6 |
OHP7D7.2.3 |
mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against 17alpha-hydroxyprogesterone. |
|
41 | luciferase-expressing cancer cells |
JCRB1373 |
BT-549-Luc |
human |
mammary gland; breast |
Luciferase stably expressing cell line (BT-549:Human Breast Cancer). |
|
42 | general cells |
JCRB1505 |
Ishikawa 3-H-12 |
human |
Endometrium |
Estrogen receptor (ER), progesterone receptor (PR) expressing cell line. |
|
43 | general cells |
JCRB1636 |
pREP4 c/CHO-S #5/sf |
hamster, Chinese |
ovary |
pREP4-cont transfected CHO-S cells (cell freezed by 10% DMSO + 90% FBS). |
|
44 | general cells |
JCRB1648 |
ICH-ERMS-1 |
human |
pelvic tumor |
Human cell derived from anaplastic embryonal rhabdomyosarcoma. |
|
45 | general cells |
JCRB1775 |
KKK-D068 |
human |
Intrahepatic bile duct |
Human well differentiated tubular adenocarcinma cell line established from biliary tract. (with micropapillary foci) |
|
46 | general cells |
JCRB1828 |
NALM-25 |
human |
peripheral bood |
Biphenotypic (B-cell and myeloid cell features) t(9;22)-positive acute lymphoblastic leukemia cell line.
Derived from the same patient as NALM-24 |
|
47 | general cells |
JCRB1891 |
OCUT-1C |
human |
thyroid |
human anaplastic thyroid cancer cell line
|
|
48 | general cells |
JCRB1897 |
OCUT-1F |
human |
thyroid |
human anaplastic thyroid cancer cell line |
|
49 | general cells |
JCRB1941 |
TU-KatoIII |
human |
Pleural effusion |
Cell line isolated as 100% tumor-forming cells after tumor formation in immunodeficient mice (NOD Scid→Scid→nu/nu). |
|
50 | general cells |
JCRB2214 |
A9(Hygro14) |
human chromosome-introduced |
skin |
contains human chromosome #14 (MTA with Tottori Univ. is required.) |
|
51 | general cells |
JCRB2216 |
A9(Neo16) |
human chromosome-introduced |
skin |
contains human chromosome #16 (MTA with Tottori Univ. is required.) |
|
52 | general cells |
JCRB9030 |
P3X63-Ag8.653 |
mouse |
peripheral blood |
myeloma, non-secreting, 8-azaguanine resistant, (BALB/c mouse) |
|
53 | general cells |
JCRB9058 |
RPMI 2650 |
human |
nasal septum |
quasi-diploid squamous carcinoma |
|
54 | general cells |
JCRB9077 |
MMT 060562 |
mouse |
mammary tumor |
spontaneous mammary tumor |
|
55 | general cells |
JCRB9128 |
Mv 1 Lu |
mink |
lung |
useful for focus forming assays of murine and feline sarcoma virus |
|
If you wish you add additional cell lines to your order, please click the "Additional order" button below.
It will close the current window and allow you to add additional cell lines to your order.
If you are ready to proceed and place your order, please click on the "Order form (SSL)" button below.